Clarus Wealth Advisors Humacyte, Inc. Transaction History
Clarus Wealth Advisors
- $222 Million
- Q3 2025
A detailed history of Clarus Wealth Advisors transactions in Humacyte, Inc. stock. As of the latest transaction made, Clarus Wealth Advisors holds 39,971 shares of HUMA stock, worth $69,149. This represents 0.03% of its overall portfolio holdings.
Number of Shares
39,971
Previous 39,971
-0.0%
Holding current value
$69,149
Previous $83,000
16.87%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
166Shares Held
54.4MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$12.1 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$7.6 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$5.93 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$5.1 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $178M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...